Recently TASK investigator Dr Caryn Upton traveled to Dallas, Texas in the United States to attend the annual American Thoracic Society conference to present a poster on a case report. The case presented was regarding a patient enrolled on a clinical trial with asymptomatic TB in the brain who appears to have been successfully treated…
TASK Applied Science (TASK) is a clinical research organisation in Cape Town, South Africa with a focus on performing clinical trials in tuberculosis (TB). TASK provides assistance to efficiently conduct studies for diagnosis, treatment or prevention of tuberculosis, as well as for other prevalent diseases such as asthma, osteoarthritis and vaccine studies, where new and improved treatments are urgently needed.
The company was founded in 2005 by Prof. Andreas Diacon to accelerate the development and evaluation of novel anti-tuberculosis drugs. TASK mainly collaborates with international NGOs, government funded consortia, academic centers and pharmaceutical companies on various drug development projects.
TASK now employs over 150 staff members, has invested in state of the art bio-safety level 3 laboratory capacity as well as a network of clinical sites in Cape Town and the Western Cape.